Template:Enalapril: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) |
Ahmed Zaghw (talk | contribs) No edit summary |
||
(9 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}} {{AZ}}, {{AM}} | ||
===''Enalapril''=== | ===''Enalapril''=== | ||
* [[Enalapril maleate tablet]] | * [[Enalapril tablet|Enalapril maleate tablet]] | ||
* [[ | * [[Enalaprilat injection]] | ||
===''[[Enalapril and Hydrochlorothiazide]]''=== | ===''[[Enalapril and Hydrochlorothiazide]]''=== | ||
* [[Enalapril maleate and Hydrochlorothiazide tablet]] | * [[Enalapril maleate and Hydrochlorothiazide tablet]] | ||
===''[[Enalapril and Felodipine]]''=== | |||
* [[Enalapril maleate and Felodipine tablet]] | |||
==Overview== | ==Overview== | ||
''' | '''Enalapril''' tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of [[hypertension]], [[heart failure]], left ventricular dysfunction after [[myocardial infarction]], [[diabetic nephropathy]]. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. [[hypotension]], [[rash]], [[hyperkalemia]], disorder of taste, [[cough]]. | ||
==Category== | ==Category== | ||
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors. | Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors. |
Latest revision as of 13:11, 9 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]
Enalapril
Enalapril and Hydrochlorothiazide
Enalapril and Felodipine
Overview
Enalapril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.
Category
Antihypertensive Agents, Angiotensin Converting Enzyme Inhibitors.